Доступ предоставлен для: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Выходит 6 номеров в год

ISSN Печать: 1045-4403

ISSN Онлайн: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Ductal Carcinoma In Situ: A Brief Review of Treatment Variation and Impacts on Patients and Society

Том 24, Выпуск 4, 2014, pp. 281-286
DOI: 10.1615/CritRevEukaryotGeneExpr.2014011495
Get accessGet access

Краткое описание

Nearly 20% of all breast cancer cases are ductal carcinoma in situ (DCIS), with over 60,000 cases diagnosed each year. Many of these cases would never cause clinical symptoms or threaten the life of the woman; however, it is currently impossible to distinguish which lesions will progress to invasive disease from those that will not. DCIS is generally associated with an excellent prognosis regardless of the treatment pathway, but there is variation in treatment aggressiveness that seems to exceed the medical uncertainty associated with DCIS management. Therefore, it would seem that a significant proportion of women with DCIS receive more extensive treatment than is needed. This overtreatment of DCIS is a growing concern among the breast cancer community and has implications for both the patient (via adverse treatment-related effects, as well as out-of-pocket costs) and society (via economic costs and the public health and environmental harm resulting from health care delivery). This article discusses DCIS treatment pathways and their implications for patients and society and calls for further research to examine the factors that are leading to such wide variation in treatment decisions.

Ключевые слова: breast cancer, DCIS, treatment
ЦИТИРОВАНО В
  1. Lesurf Robert, Aure Miriam Ragle, Mørk Hanne Håberg, Vitelli Valeria, Lundgren Steinar, Børresen-Dale Anne-Lise, Kristensen Vessela, Wärnberg Fredrik, Hallett Michael, Sørlie Therese, Sauer Torill, Geisler Jürgen, Hofvind Solveig, Borgen Elin, Børresen-Dale Anne-Lise, Engebråten Olav, Fodstad Øystein, Garred Øystein, Geitvik Gry Aarum, Kåresen Rolf, Naume Bjørn, Mælandsmo Gunhild Mari, Russnes Hege G., Schlichting Ellen, Sørlie Therese, Lingjærde Ole Christian, Kristensen Vessela, Sahlberg Kristine Kleivi, Skjerven Helle Kristine, Fritzman Britt, Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer, Cell Reports, 16, 4, 2016. Crossref

  2. KURONO Kenji, KAWASHIMA Taichi, KAWAKAMI Makio, A Case of Noninvasive Her2-positive DCIS with Multiple Recurrences Involving the Liver, Bone and Lung 3 Years after Surgery, Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 78, 6, 2017. Crossref

  3. Martinez Leandro M., Robila Valentina, Clark Nicholas M., Du Wei, Idowu Michael O., Rutkowski Melanie R., Bos Paula D., Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer, Frontiers in Immunology, 10, 2019. Crossref

  4. Margolis Ryan, Wessner Corinne, Stanczak Maria, Liu Ji-Bin, Li Jingzhi, Nam Kibo, Forsberg Flemming, Eisenbrey John R., Monitoring Progression of Ductal Carcinoma In Situ Using Photoacoustics and Contrast-Enhanced Ultrasound, Translational Oncology, 12, 7, 2019. Crossref

  5. DURHAN Abdullah, SÜLEYMAN Marlen, KOŞMAZ Koray, ŞENLİKCİ Abdullah, ERGÜDER Ender, BAĞ Yusuf Murat, PEKCİCİ Mevlüt Recep, EREL Serap, Evaluation of Surgical and Systemic Treatment Results in Patients with Ductal Carcinoma In Situ, Journal of Contemporary Medicine, 11, 3, 2021. Crossref

  6. Atwell Lauren L., Zhang Zhenzhen, Mori Motomi, Farris Paige E., Vetto John T., Naik Arpana M., Oh Karen Y., Thuillier Philippe, Ho Emily, Shannon Jackilen, Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy, Cancer Prevention Research, 8, 12, 2015. Crossref

  7. Chien Ju-Chun, Liu Wen-Shan, Huang Wei-Tzu, Shih Liang-Chung, Liu Wen-Chung, Chen Yu-Chia, Chou Kang-Ju, Shiue Yow-Ling, Lin Pei-Chin, Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy, The Breast, 63, 2022. Crossref

758 Просмотры статей 38 Загрузка статей Метрики
758 ПРОСМОТРЫ 38 ЗАГРУЗКИ 7 Crossref ЦИТАТЫ Google
Scholar
ЦИТАТЫ

Статьи с похожим содержанием:

Recent Advances in Herbal Drug Nanocarriers against Cervical Cancer Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.38, 2021, issue 1
Sujata P. Sawarkar, Mansi Damani, Krishna Baxi, Clara Aranha
Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications Critical Reviews™ in Oncogenesis, Vol.27, 2022, issue 2
Nira Ben-Jonathan, Eric R. Hugo, Dana C. Borcherding
A Partial Review of the Appropriate Use of Opioid Analgesics in the Treatment of Chronic Pain: Toward a Model of Good Practice and Rational Pharmacotherapy Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.21, 2009, issue 1
John Burke, John F. Peppin, Kenneth L. Kirsh, Gerry Klim
Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Devasis Chatterjee, Austin DeChalus, Peter J. Quesenberry, Andrew R. Mendelsohn, Joseph F. Renzulli II, Justin Q. Wang, Giovanni Camussi, Devin N. Chatterjee, Atsushi Mizokami, Evan T. Keller
Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 3
Rohit Bhosale, Bannimath Gurupadayya, Devegowda Vishakante Gowda, Koganti Venkata Sairam, Riyaz Ali Mahafez Ali Osmani, Rudra Vaghela, Hosahalli Veerabhadrappa Gangadharappa, Parthasarathi Keshavarao Kulkarni

Статьи, принятые к публикации

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain